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Hereditary hearing loss is characterized by a high degree of genetic heterogeneity. Here we presentOTOGLmutations, a homozygous one
base pair deletion (c.1430 delT) causing a frameshift (p.Val477Glufs*25) in a large consanguineous family and two compound hetero-
zygous mutations, c.547C>T (p.Arg183*) and c.5238þ5G>A, in a nonconsanguineous family with moderate nonsyndromic sensori-
neural hearing loss. OTOGL maps to the DFNB84 locus at 12q21.31 and encodes otogelin-like, which has structural similarities to the
epithelial-secreted mucin protein family. We demonstrate that Otogl is expressed in the inner ear of vertebrates with a transcription level
that is high in embryonic, lower in neonatal, andmuch lower in adult stages. Otogelin-like is localized to the acellular membranes of the
cochlea and the vestibular system and to a variety of inner ear cells located underneath these membranes. Knocking down of otogl with
morpholinos in zebrafish leads to sensorineural hearing loss and anatomical changes in the inner ear, supporting that otogelin-like is
essential for normal inner ear function. We propose that OTOGLmutations affect the production and/or function of acellular structures
of the inner ear, which ultimately leads to sensorineural hearing loss.Introduction
Hereditary hearing loss is characterized by genetic hetero-
geneity with mutations in several hundreds of genes
encoding a variety of proteins.1–3 Mutations in these genes
lead to various clinical scenarios ranging from nonsyn-
dromic hearing loss to one of the more than 400
syndromes that include hearing loss and from mild adult
onset hearing loss to profound congenital deafness span-
ning a full spectrum of Mendelian inheritance.1,2 The
autosomal recessive pattern of inheritance occurs in the
majority of families with autosomal recessive nonsyn-
dromic hearing loss (arNSHL) and is typically congenital
or prelingual-onset.2 Mutations in 40 genes have thus far
been shown to cause arNSHL, which can account for
more than 60% of families with this type of inheritance
pattern.3 Hearing loss is usually severe or profound in
cases with arNSHL, although varying degrees of residual
hearing are observed in some families. Individuals with
mutations in STRC (MIM 606440), for example, essentially
present with moderate hearing loss4 and 22% of the
persons with mutations in the DFNB1 locus have
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872 The American Journal of Human Genetics 91, 872–882, NovembIn this study, we report mutations in OTOGL, encoding
otogelin-like, that are associated with moderate arNSHL.
We demonstrate that OTOGL is expressed in the inner
ears of humans, mouse, rat, and zebrafish, and its disrup-
tion in zebrafish leads to hearing loss.Materials and Methods
Studied Families
The study on hereditary deafness was approved by the Ethics
Committees of Ankara University (Turkey) and the Radboud
University Nijmegen Medical Centre (The Netherlands), and by
the IRB at the University of Miami (USA). Informed consents
were obtained from all participants, or in the case of minors,
from the parents. Diagnosis of sensorineural hearing loss was
established via standard audiometry in a sound-proofed room
according to current clinical standards. Hearing loss was classified
according to the GENDEAF guidelines (hereditary hearing loss
homepage). Evaluation for vestibular function included Unter-
berger, Romberg, head thrust, and head shake tests, oculomotor
examination, spontaneous nystagmus and positioning tests, and
bithermal caloric tests via videonystagmography (VNG, Micro-
medical Technologies, Illinois USA). Slow component velocity
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Figure 1. Studied Families, Audiograms,
and OTOGL Mutations
(A) Family 1 and the longest autozygous
region on chromosome 12. Parents are first
cousins.
(B) Audiograms show moderate sensori-
neural hearing loss in family 1.
(C) Electropherograms showing identified
mutations in OTOGL in family 1.
(D) PedigreeandSNPgenotypes in family2.
(E) Audiograms of affected subjects in
family 2 show moderate hearing loss.
(F) Electropherograms of the OTOGL
mutations identified in family 2.6 deg/s. Clinical evaluation of all affected individuals by a geneti-
cist and an ENT surgeon included a thorough physical examina-
tion and otoscopy. A high resolution CT scan of the temporal
bone was obtained in one affected person in each family. The
studies presented here were performed in two families: family 1,
a consanguineous Turkish family with four children (Figure 1A)
and family 2, a nonconsanguineous Dutch family with three
children having sensorineural hearing loss (Figure 1D). DNA was
extracted from blood via standard methods. One affected indi-
vidual from each family was prescreened and found not to have
common causes of nonsyndromic deafness including mutations
in GJB2 (MIM 121011) and for the m.1555A>G mutation in
MTRNR1 (MIM 561000).
Autozygosity Mapping
Genome-wide SNP genotyping was performed via Affymetrix 6.0
and Illumina Human Omni Express 700K arrays in families 1 andThe American Journal of Human Gen2, respectively. Autozygosity mapping was
performed as reported previously.6,7 The
cosegregation of the genotypes for each
previously reporteddeafness genewasvisu-
ally evaluated. Multipoint linkage analysis
of an autozygous segment was conducted
with GeneHunter,8 assuming a fully pene-
trant autosomal recessive phenotype with
population frequency for the hearing loss
allele of 0.0001. SNPs spanning the autozy-
gous region were chosen for linkage anal-
ysis based on tagging and heterozygosity
in the parents. Copy number variants
(CNVs) were assessed by determining the
relative loss or gain of fluorescent signal
intensity from SNP or CNV probes on the
array as previously described.6
Whole Exome and Sanger
Sequencing
The Agilent SureSelect Human All Exon 50
MB kit was used with an Illumina HiSeq
2000 instrument. Adaptor sequences for
the Illumina HiSeq2000 were ligated and
the enriched DNA samples were subjected
to standard sample preparation for the
HiSeq2000 instrument (Illumina). Paired-
end reads of 100 bases length were pro-
duced. The Illumina CASAVA v1.8 pipelinewas used to produce 99 bp sequence reads. BWA9 was used to align
sequence reads to thehumanreferencegenome (hg19) andvariants
were called using the GATK software package.10 All variants were
submitted to SeattleSeq135 for further characterization.
All 58 exons and exon-intron boundaries of OTOGL
(NM_173591.3) were screened via Sanger-sequencing (detailed in
Table S1 available online). To screen additional families for linkage
to the OTOGL locus, eight SNPs within the gene were chosen, and
custom TaqMan probes were developed and assayed according to
the manufacturer’s protocol. Data were analyzed via SDS 2.3
(Applied Biosystems) software.
Minigene Construction and Splicing Assay
For prediction of the effect of the c.5238þ5G>A transition
on splicing efficiency, the following software tools were used:
NetGene,11 BDGP Splice prediction site,12 and Human Splice
Finder (Alamut; Interactive Biosoftware).etics 91, 872–882, November 2, 2012 873
The splicing assay for the c.5238þ5G>A mutation was per-
formed using the pCIneo vector described by Gamundi et al.
containing exons 3–5 of RHO,13 which was adapted for the
Gateway cloning system by replacing exon 4 and flanking
sequences by a Gateway cassette using the EcoNI and PflMI sites
of the vector. A fragment containing exon 43 and 225 and
126 bp respectively of 50and 30 flanking sequences of OTOGL
was amplified from genomic DNA of one of the parents of family
2 and clones for the wild-type (WT) and the mutant alleles were
selected after sequencing. Primers used for amplification of the
fragment are provided in Table S2. Transfection of HEK293T cells
with the plasmids, isolation of RNA, and RT-PCR were performed
as described.14 The RHO and OTOGL exons were amplified from
the complimentary DNA (cDNA) with forward primer 50- cggaggt
caacaacgagtct-30 and reverse primer 50-aggtgtaggggatgggagac-30,
which are located in RHO exon 3 and exon 5, respectively. The
assay was performed in triplo in two independent experiments.
The RT-PCR fragments were sequenced to verify normal splicing
and exon skipping.
OTOGL Expression Profile by Quantitative PCR
in Humans
RNA derived from various adult tissues as well as from fetal liver
was purchased from Clontech. In addition, RNA was isolated
from fetal inner ear, heart, skeletal muscle, and lung as described
previously.15 cDNA was synthesized as previously described15
and purified with NucleoSpin Extract II columns (Macherey-
Nagel) in accordance with the manufacturer’s protocol. For PCR,
specific primers (Table S2) were designed with Primer3Plus and
reference sequence NM_173591.3. Amplifications were performed
with the Applied Biosystem Fast 7900 System in accordance with
the manufacturer’s protocol. The human beta glucuronidase gene
(GUSB; MIM 611499) was employed as an internal reference. PCR
reaction mixtures were prepared with the Power SYBR Green
Master Mix (Applied Biosystems) in accordance with the manufac-
turer’s protocol. Temperatures and reaction times for PCR were as
follows: 10 min at 95C, followed by 40 cycles of 15 s at 95C and
30 s at 60C. All reactions were performed in duplicate. Relative
gene expression levels were determined with the delta delta Ct
method as described previously.16
Otogl Expression by Semiquantitative RT-PCR in Mice
Otogl transcript levels in different developmental stages of mouse
inner ear were evaluated by semiquantitative RT-PCR. All the
procedures were approved by the Institutional Animal Care and
Use Committee of the Massachusetts Eye and Ear Infirmary.
Mouse cochleae were dissected from CD1 mice at different stages.
RNA extractions were performed using Trizol reagent (Life Tech-
nologies). Reverse transcriptase reactions were performed using
SuperScript II (Life Technologies), and PCR reactions using Taq
polymerase (Life Technologies). The PCR primers are given in
Table S2. PCR conditions were: 94C, 2 min; 94C, 30 s; 62C,
1 min; 72C, 1 min 30 s for 40 cycles; 72C, 10 min. Gene expres-
sion was normalized to GAPDH expression.
Rodent Immunohistochemistry and In Situ
Hybridization
CD1mouse inner ear tissues from timed pregnancy were collected
following an established procedure. The procedure in the use of
animals and tissue preparation were approved by the Institutional
Animal Care and Use Committee of theMassachusetts Eye and Ear874 The American Journal of Human Genetics 91, 872–882, NovembInfirmary and of the Radboud University Nijmegen. Standard
immunohistochemical procedures were used for the labeling of
cryosectioned mouse cochlear slides, with the antibodies against
the following antigens: otogelin-like (OTOGL) (1:150, Atlas
Antibodies, HPA040364), SOX2 (1:200, Santa Cruz, sc-17320),
MYO7A (1:1,000, Developmental Studies Hybridoma Bank,
MYO7A 138-1). The nuclei were labeled with DAPI (1X, Molecular
Probe).
For the preadsorption control experiment, the OTOGL antibody
was incubated with 10-fold excess (relative to antibody concentra-
tion) of OTOGL antigen (Atlas Antibodies, HPA040364, dissolved
in 1M urea and 13 PBS) at room temperature for 2 hr. The mixture
was spun at 16,000 g for 20’, and the supernatant was used for
immunofluorescence. The MYO7A antibody was also mixed
with OTOGL antigen and antibody on the same condition and
the MYO7A staining was not different from the pattern using
the nontreated MYO7A antibody. The image acquisition condi-
tions were identical for all immunolabeling results.
Temporal bones of P10, P20, and P30 Wistar rats were fixed in
2% buffered paraformaldehyde, before dissection of the cochlea
and vestibular structures. For these cryosections, the OTOGL anti-
body was 1:50 diluted and Alexa Fluor 568 labeled phalloidin
(1:400; Life Technologies) was added for actin staining. The nuclei
were labeled with DAPI (1X,Molecular Probe) and for controls, the
primary antibody was omitted. Sections were examined with
a fluorescence microscope. In addition, 2% paraformaldehyde
fixed whole mount organs of Corti of P12 rats were incubated
with anti-otogl (1:50), phalloidin (1:400), and DAPI (1:8,000) as
previously described17 and analyzed with a confocal microscope.
For in situ hybridization, the same sample preparation for
mouse inner ear tissue was used as in immunohistochem-
istry. The protocol used was identical to the one described
previously.18
Zebrafish otogl Identification, Cloning, In Situ
Hybridization, and Immunohistochemistry
Zebrafish (Danio rerio) were raised and handled following standard
techniques19 approved by the Institutional Animal Care and Use
Committee of the University of Miami. Embryos from WT AB
stock were used for gene cloning and enhancer trap transgenic
line SqET420 expressing GFP in hair cells for expression analysis
and physiology. We identified the zebrafish homolog of the
human OTOGL by sequence similarity and synteny analysis. The
human OTOGL protein sequence NP_775862.3 was used to query
the zebrafish genome version 9 by BLAT using VEGA Genome
Browser (release 46), the manually curated zebrafish genomic
database. Two high-scoring genomic loci were recovered, dkeyp-
27b10.2, a predicted otogl gene (BX321877.7) on chromosome
18 and (BX842701.1-201) on chromosome 7 that encodes zebra-
fish otog. Separately, linkage analysis of the zebrafish genes to
ptprq, a deafness gene that in humans is closely linked to
OTOGL,7,21 showed that only dkeyp-27b10.2 is closely associated
to the zebrafish ptprq. Based on sequence and synteny evidence,
we established the zebrafish gene on chromosome 7 as the ortho-
log of human OTOG on chromosome 11 and dkeyp-27b10.2 on
chromosome 18 as the ortholog of human OTOGL on chromo-
some 12. The zebrafish nomenclature committee reviewed and
approved these name designations, assigning the Zebrafish Infor-
mation Network (ZFIN) number ZDB-GENE-120228-1 to otogelin
(otog) and ZDB-GENE-050419-93 to otogl.
An 800 base pair region of zebrafish otogl near the center of the
gene that was devoid of repetitive protein domains was cloneder 2, 2012
using an RT-PCR strategy. Nested primers were designed using
the zebrafish genome assembly version 9. cDNA from 48 hpf
embryos was PCR amplified with Taq polymerase (Promega) and
primer set 5out-otogl, TGGAGGAAGGAGTCTGCT and 3out-
otogl, CACGGTCACAGGTGCATT. A second round of amplifica-
tion used inner primers 5in-otogl, GAGTCTGCTGTCCCAAGA
and 3in-otogl, CAACCGCAGTCTCCATAC. The PCR cycling
parameters used for both reactions was as follows: 94C, 2 min,
1 time; 94C, 30 s, 60C, 1 min, 72C, 2 min, 35 times; 72C,
10 min, 4C, hold, 1 time. PCR product was gel purified, and
ligated to pGEM-T Easy (Promega) using manufacturer’s instruc-
tions. Eight clones were sequenced to verify identity of inserts.
One plasmid containing the correct insert was linearized and
in vitro transcribed to generate DIG-labeled RNA to use as a
probe. Whole-mount in situ hybridization was carried out as
previously described,22 with the following modification: prior to
developing the chromogenic reaction with Fast Red substrate
(Roche), embryos were immunostained to detect GFP expression
in ear hair cells.
Immunodetection of GFP and acetylated-tubulin in zebrafish
embryos was done following a previously described protocol.23
Anti-GFP (Anaspec) and anti-acetylated tubulin (Santa Cruz
Biotechnology) were used as primary antibodies and an anti-rabbit
Alexa488-conjugated antibody as a secondary antibody (Life Tech-
nologies). Actin was detected using Alexa568-conjugated phalloi-
din (Life Technologies). Immunostaining and in situ hybridization
were performed via standard methods.23
Zebrafish otogl Morpholino Knockdown
To generate zebrafish larvae lacking otogl function, we first identi-
fied the gene’s intron/exon junctions by comparing Otogl protein
sequence XP_683212 to the otogl genomic region of VEGA.We de-
signed two splice-blockingmorpholinos against exon/intron junc-
tions 36 and 37 found at the 30 half of the gene because the gene’s
50 end is poorly annotated. Missplicing events at these locations
were predicted to generate truncated proteins lacking the last
von Willebrand Factor (vWF)/cytokine rich paired domains and
C-terminal cysteine knot domain. The two splice-blocking mor-
pholinos (GeneTools, LLC) are MO1 GATGCACACACACACT
GACCGCAGA against exon/intron junction 36 and MO2
CATCCTGAGGAAAGGAGGGTAACAC against exon/intron junc-
tions 37. The efficacy of otogl knockdown by each morpholino
was assessed by RT-PCR analysis of morpholino-induced intron
retention. Total RNA was extracted from 3-day-old embryos using
Trizol (Life Technologies) and treatedwith Turbo DNase (Ambion).
Purified 500 ng RNA was reverse transcribed to cDNA using
an anchored oligodT primer and Superscript III (Life Technolo-
gies). cDNA (1 ml) was then used as template for a PCR react-
ion with diagnostic primers TACCACAGCACTGGCATCAT and
TTCCTCCAGCTGAAGCAGAT that span the exon/intron junc-
tions targeted by the morpholinos. Primers against an unrelated
gene, the glycine receptor b subunit (glrbb) serves as a loading
control. Morpholinos were titrated to determine the lowest dose
that induced missplicing events. Physiology and molecular
biology were carried out on embryos injected with 2–5 nL of
0.25 mM otoglMO1 or otoglMO2. For phenotypic assessment,
otogl MO-injected larvae were compared to stage-matched larvae
injected with the same concentration of a standard control
morpholino CCTCTTACCTCAGTTACAATTTATA (GeneTools,
LLC). Both otogl morpholinos produced similar phenotypes that
include severe cardiac edema and, at higher doses, curvature to
the body axis.The AmericanMicrophonic Potential Recording in Zebrafish
The microphonic potential recording from larval zebrafish was
modified from previously described protocols.24,25 Morpholino-
injected zebrafish at 2 or 3 dpf were anaesthetized in 0.01% buff-
ered MS-222 solution and embedded dorsal up in 1.8% agarose
with 0.01% buffered MS-222 in a low profile 35 mm MatTek
dish. TheMatTek dish was then placed in a QE-1 platform (Warner
Instruments, Hamden, CT) that was temperature controlled at
about 28.5C on a Gibraltar stage of Zeiss Axioskop 2 FS plus
microscope. The Zeiss microscope setup rested on an antivibration
table and enclosed in a Faraday cage (Technical Manufacturing,
Peabody, MA).
A stimulus probe with the tip size of 20 mm in diameter
was made from a glass capillary (OD ¼ 1.50 mm, ID ¼ 0.84 mm,
World Precision Instruments, Sarasota, FL) using a micropipette
puller (P97, Sutter Instrument Co., Novato, CA) and a microforge
(MF-900, Narishige International USA, East Meadow, NY). The
stimulus probe was driven by a piezoelectric actuator and cali-
brated using a high-speed camera. The probe tip was placed
against the posterior edge of the inner ear (pointing to the saccular
otolith) and provided linear oscillatory motion at 200 Hz along an
axis parallel to the longitudinal axis of fish body.
The recording electrodes were made from glass capillaries
(OD ¼ 1.5, ID ¼ 1.12 mm, WPI), filled with standard fish saline
solution (pH ¼ 7.2) and then sharpened with a Sutter BV-10-E
micropipette beveler until the electrode resistance dropped to
about 6 MU. The recording electrode tip was advanced to pene-
trate the wall of the inner ear of larval zebrafish using a Narishige
MHW-3 three-dimensional hydraulic micromanipulator. Micro-
phonic responses were amplified 1,0003, band-pass filtered
between 0.1 and 3000 Hz, averaged up to 200 times, and recorded
at a sampling rate of 25 kHz. The amplitude of microphonic
responses (RMS) was measured at twice the stimulus frequency
in FFT plots. Student’s t test was performed to determine the signif-
icance of differences in microphonic amplitude between otogl
morphants and larvae injected with a control morpholino.Results
OTOGL Mutations Cause Moderate Sensorineural
Hearing Loss in Humans
In family 1, all four affected individuals had symmetric
moderate sensorineural hearing loss. Available audiograms
did not show progression (Figure 1B; Figure S1). Clinical
examinations did not reveal additional findings. CT scan
of the temporal bone of one affected family member was
normal as well. Detailed vestibular analyses were per-
formed in one individual, II:7, who complained about
one episode of dizziness lasting for 3 months at age 17.
He described it as a blurry vision caused by turning his
head abruptly to the left and lasting for only a few seconds.
There were no other symptoms such as vertigo. Vestibular
tests revealed vestibular hypofunction on the left side via
caloric tests. All positional tests produced persistent up-
left nontorsional nystagmus with the average of 7 deg/s
without vertigo sensation.
Only one autozygous genomic region larger than 1 Mb
was shared by all four affected members of family 1. The
length of this autozygous region was 15 Mb onJournal of Human Genetics 91, 872–882, November 2, 2012 875
Table 1. The Number of Variants, SNPs and Indels, Identified by
Whole Exome Sequencing of One Individual in Family 1 Compared
to the Reference Genome hg19. The Different Filters and
Annotation Categories Are Shown
Region Total Variants Novel Variants
Whole exome 221,686 77,655
þHomozygous variants 64,180 2,828
þChr12:68,804,480-83,923,162 407 38
þMissense, nonsense, splice,
frameshift
16 2
Sanger confirmed NA 2 in OTOGL
NA, not available.chromosome 12 (68,804,480–83,923,162 bp) and included
the DFNB84 locus (Figure 1A). The autozygous region
contains 51 RefSeq genes including PTPRQ (MIM
603317), which was recently found to be associated with
arNSHL.7,21 A multipoint LOD score of 3.36 was obtained
for this region. Sanger-sequencing of the exons and
intron-exon boundaries of PTPRQ (NM_001145026.1) in
one affected member did not show a mutation. None of
the other previously identified deafness genes mapped to
an autozygous region suggesting that a previously unrec-
ognized human deafness gene was involved in this family.
We then performed whole exome sequencing in indi-
vidual II:7, which generated 177,257,596 reads. Using
a minimum depth of 43, 84% of the targeted regions
were covered with an average read depth of 1003. The
longest autozygous region on chromosome 12 was fully
covered by SureSelect Human All Exon 50 Mb kit except
for PTPRQ, which was Sanger-sequenced in family 1. After
multiple filters were employed (Table 1), whole exome data
revealed two novel homozygous variants both located in
OTOGL (hg19): a one base pair deletion at 80,648,835,
c.1430 delT (NM_173591.3) predicted to cause a reading
frame shift and a premature termination of protein
synthesis, p.Val477Glufs*25 (NP_775862.3) and 80,717,
580T>C corresponding to c.4132T>C (NM_173591.3) pre-
dicted to lead to the substitution of an arginine for
a cysteine, p.Cys1378Arg (NP_775862.3). Both variants
were confirmed via Sanger sequencing (Figure 1C). They
both cosegregated with the phenotype in the family as
an autosomal recessive trait and were absent in 373
ethnicity-matched control samples. Neither variant
has been found in the NHLBI Exome Sequencing Pro-
ject (Exome Variant Server), or in dbSNP databases. The
p.Cys1378Arg variant affected a highly conserved residue
in OTOGL. However, because p.Cys1378Arg is located at
the C-terminal relative to p.Val477Glufs*25, it is unlikely
to contribute to the phenotype. Screening for additional
mutations in OTOGL via linkage analysis followed by
Sanger-sequencing in additional 195 families with severe
or profound arNSHL failed to detect a mutation.
Three brothers in family 2 presented moderate and
stable hearing loss. Physical examination and otoscopy876 The American Journal of Human Genetics 91, 872–882, Novembrevealed no abnormalities. Diagnosis of hearing loss was
at the neonatal hearing screening for II:3 and can therefore
be assumed to be congenital. Subsequently, the older
brothers were diagnosed at the ages of 3 (II:1) and 2 (II:2)
years. All three boys performed normally in the Unter-
berger, Romberg, head thrust, and head shake tests, and,
in addition, the eye tracking movements, although a delay
in gross motor development was reported. A high resolu-
tion CT scan in II:3 did not reveal abnormalities. Auto-
zygosity mapping in family 2 did not reveal any significant
homozygous regions (>1 Mb) shared by all three affected
children. As a next step, the data were analyzed for the
presence of shared genotypes (>3Mb) in the three affected
children for the previously described autosomal recessive
deafness loci; a shared region of 10.9 Mb on chromosomal
region 12q21.2-q21.32 was identified encompassing the
DFNB84 locus. Because of the moderate, stable nature of
the hearing impairment that was also noted in family 1,
we initiated mutation analysis of OTOGL. Two variants,
which were not present in the NCBI dbSNP134 or 135
database, NHLBI Exome Sequencing Project (Exome
Variant Server), nor in the 1000 Genomes Project, were
identified; a nonsense mutation c.547C>T (p.Arg183*)
and a splice site mutation c.5238þ5G>A. All three affected
children were compound heterozygous for these muta-
tions; father and mother were heterozygous for
p.Arg183* and c.5238þ5G>A, respectively. The splice site
mutation is predicted to reduce splicing efficiency by
~50% (0.47 versus 0.98 for the WT sequence; BDGP Splice
Prediction). Two other prediction tools, NetGene Splice
site predictions and Human Splice Finder, do not predict
a splice donor site for the sequence with the G to A transi-
tion. A minigene assay was performed to test the effect of
the mutation on splicing in HEK293T cells, which demon-
strated skipping of exon 43 (Figure S2).
Otogelin-like, the predicted product of Otogl, was
recently identified in mouse by amplification and
sequencing of the transcript. The gene was annotated
and named because of its structural similarity to otoge-
lin.21 Otogelin encoded by Otog was first discovered as an
extracellular glycoprotein specific to the acellular
membranes of inner ear.26 Otogelin shows structural simi-
larities to the epithelial-secreted mucin protein family
because it comprises anN-terminal signal peptide, a central
threonine/serine/proline-rich (TSP) region flanked by
vWF-like cysteine-rich domains, and a C-terminal knot
motif domain.26 Otogelin-like similarly contains an
N-terminal signal peptide of 22 amino acids in the
N-terminal (predicted by the SignalP software) as well as
vWF and knot domains in the mature peptide
(Figure 4B). Otogelin and otogelin-like have an amino
acid identity of 33.3% (56.0% similarity).
Expression Profile of OTOGL
The expression of OTOGL relative to GUSB standard
internal control was studied via quantitative PCR (qPCR)
in ten adult and ten fetal-stage human tissues includinger 2, 2012
Figure 2. OTOGL Expression Profile in Human Tissues
Relative OTOGL mRNA levels as determined by qPCR in human
fetal (A) and adult (B) tissues. The relative expression values were
determined by using the delta delta Ct method. Relative OTOGL
transcript levels were highest in fetal inner ear.human fetal inner ear (Figure 2). Because this was per-
formed for adult and fetal tissues in two separate experi-
ments, fetal inner ear was included in both for comparison.
In adult tissues, relatively low OTOGL transcript levels as
compared to fetal inner ear were seen in lung, spleen,
and duodenum and relatively moderate levels in heart,
kidney, brain, and retina. In three of the adult tissues—
skeletal muscle, liver and testis—expression of OTOGL
was below the detection level. Among the fetal tissues
that were tested, the transcript level was highest in the
inner ear. However, because these tissues were not derived
from fetuses of the same gestational stage, a direct compar-
ison of the transcript levels cannot be made. The inner ear
was derived from a fetus at 8 weeks of gestation and all
other fetal tissues from fetuses at 20–21 weeks gestation.
At the latter stage, OTOGL transcript levels were highest
in fetal heart. A low relative OTOGL transcript level was
observed in skeletal muscle, kidney, spleen, and colon. In
the fetal liver, lung, brain, and stomach, expression was
below the detection level.
Otogelin-like Is Present in Several Cell Types and the
Acellular Membranes of the Inner Ear
The localization of OTOGL in the inner ear was studied by
immunostaining with an anti-OTOGL antibody in the
mouse and rat. Furthermore, we analyzed the transcription
of otogl by in situ hybridization in the mouse and zebrafish
and by semiquantitative RT-PCR in the mouse. Overall
OTOGL showed a dynamic expression pattern throughout
development, and immunostaining and in situ results
were consistent with each other. At E17.5, OTOGL wasThe Americanprimarily detected in the spiral prominence and the
Claudius cells and weakly in hair cells (Figures 3A and
3B). It was detected in the lumen surface of interdental
cells in the proximity of Reissner’s membrane (Figure 3A,
arrowhead) and in the base of nascent tectorial membrane
(Figure 3A, arrow). A similar OTOGL distribution was de-
tected in P0 cochlea (Figure 3C), with additional detection
in some supporting cells. In saccule, OTOGL was detected
weakly in hair cells and more prominently in the saccular
roof (Figure 3E). By P6, OTOGL distribution became more
restricted. It was detected mainly in the outer hair cells,
Deiters cells, and Claudius cells (Figure 3F). In the tectorial
membrane, it was localized to the base (Figure 3F, arrow).
In the saccule, elevated level was detected in the saccule
roof with little change in the hair cells (Figure 3H). To
study the specificity of the antibody staining, we per-
formed preadsorption with a synthesized peptide con-
taining the OTOGL antigen as control. Preadsorption
abolished the signals revealed by the OTOGL antibody
but did not affect Myo7a (Figure 3G), demonstrating the
specificity of the OTOGL antibody.
By semiquantitative RT-PCR,Otoglwas upregulated up to
P13 in the cochlea and downregulated in the adult. In
addition to the inner ear, Otogl transcript was detected
weakly in the cortex, but not in the hippocampus
(Figure 3J).
In the rat, OTOGL continued to be present in various
inner ear cells, particularly in Hensen’s cells in the post-
natal period, and was present in the acellular membranes
and basilar membrane (Figures S3 and S4).
In zebrafish, otogl transcription during the first 5 days of
larval development was confined to the otic vesicle
(Figure 4A; data not shown). Using fluorescent in situ
hybridization, we first detected otogl transcripts at 36 hr
post fertilization in the developing macula communis
(Figure 4A).22 At later developmental stages otogl expres-
sion was also detected in the other maculae (Figure 4A
and not shown). Within the maculae, two different apical
epithelial cell populations were found to express otogl, hair
and nonhair cells (Figure 4A; data not shown). In older
larvae, otogl transcription was also seen in many basal
epithelial cells directly below hair cells (Figure 4A). Thus,
different populations of basal and apical cells associated
with the maculae express otogl.
Knocking Down otogl in Zebrafish Causes
Sensorineural Hearing Loss and Anatomical Changes
in the Inner Ear
To determine the function of otogl, we knocked down the
expression of the highly conserved Otogl protein
(XP_683212; 73.1% identity over a stretch of 746 amino
acids) in zebrafish by injecting splice-junction blocking
morpholinos (MOs) into fertilized eggs. Both human and
predicted zebrafish Otogl are large proteins, 2,343 and
2,454 aa respectively, consisting of four repeats of paired
vWF/C8 (von Willebrand Factor/cysteine rich) domains
with a C-terminal cystine knot domain (Figure 4B). OtherJournal of Human Genetics 91, 872–882, November 2, 2012 877
Figure 3. Otogl Expression and Distribu-
tion in the Mouse Inner Ear
(A and A’) In E17.5 cochlea, OTOGL was
detected by immunohistochemistry on
the lumen surface of interdental cells close
to the Reissner’s membrane (arrowhead),
the base of tectorial membrane (arrow),
hair cells (HC), Claudius cells (Cld), and
spiral prominence (SP). Figures in the
middle column (A’–G’) are merged images
that include the first column.
(B) By in situ hybridization, Otogl mRNA
was detected in the same cell types as
shownby immunostaining,with thediffer-
ence that immunolabeling also detected
staining on the surface (A, arrowhead and
arrow). Scale bars represent 20 mm.
(C) In P0 cochlea, a similar OTOGL distri-
bution pattern was detected by immuno-
staining, with clear presence in the Deiters
cells (DC). The figure on the third column
(C’’) is a merged picture from Otogl
labeling with a differential interference
contrast (DIC) image, to show the tectorial
membrane (TM).
(D) In P0 saccule, OTOGL was weakly
detected in hair cells, but prominently
detected in the saccular roof (SR). The strong
labeling on the surface of the SR was likely
the otolithic membrane. The dashed line
represents thebaseof thebasilarmembrane.
(E) In situ hybridization showed Otogl
expression in the cochlea that was consis-
tent with immunolabeling results.
(F) In P6 cochlea, OTOGL distribution was
restricted to outer hair cells (OHC), Pillar
cells, Deiters cells, and Claudius cells. In
the tectorial membrane, it was limited to
the base (arrow).
(G) Preadsorption with a synthetic OTOGL
antigen eliminated the signals reveled
by the OTOGL antibody including TM
staining.
(H) In the P6 saccule, OTOGL distribution
was similar to that at P0, however with
a higher level in the saccular roof.
(I) The level of Otogl mRNA was enhanced
in the OHC, Deiters, and Pillar cells.
(J) Semiquantitative RT-PCR of whole
cochlea showed that Otogl transcripts
were most abundant at P13 and decreased
in toward young adulthood. Otogl was also
detected in the cortex (Cor) but not in the
hippocampus (Hip). Gapdh transcript
levels were used as a control.proteins with this domain structure are mucin and otoge-
lin.26 We designed two splice-junction blocking morpholi-
nos against exon/intron 36 and 37 of the zebrafish gene
that result in protein truncations (Figures 4B and 4C).
Both otoglMO1 and otoglMO2 morphants significantly
knocked down the expression of otogl at day 2 (Figure 4C).
otoglMO2 morphants were used for inner ear morpholog-
ical analysis and physiological recordings because MO1
caused severe cardiac edema. MO2 morphant phenotypes
were characterized by mild cardiac edema, slight reduction
in larvae length (t test, p ¼ 0.007), failure to escape in878 The American Journal of Human Genetics 91, 872–882, Novembresponse to vibration stimuli, a smaller inner ear (p ¼
0.002), and smaller saccular otolith (p ¼ 0.001) (Figures
4D and 4E). There was no significant difference in size of
utricular otolith between the control and morphants
(p ¼ 0.41). Furthermore, loss of otogl function also caused
defects in the development of the tissue pillars that shape
the semicircular canals (Figures 4F and 4G). It is unclear if
these misshapen semicircular canals impacted vestibular
function, as the severe cardiac edema precluded the anal-
ysis of circling behaviors at day 5 postfertilization that
are characteristic of vestibular deficits.27 Microphonicer 2, 2012
potentials were recorded from controls and otoglMO2
morphants in response to oscillatory stimulation at
200 Hz and 5 3 mm in displacement. The microphonic
waveforms recorded had a characteristic feature of
doubling of the stimulus frequency (Figure 4H). The
average amplitude of microphonic responses that were
measured at 400 Hz in FFT plots ranged from 14 5 8 mV
(N ¼ 11) for control morphlino-injected larvae and 4 5
5 mV (n ¼ 12) for otoglmorphants (Figure 4I). Microphonic
responses of otoglmorphants are significantly smaller than
those of controls (p ¼ 0.0008).Discussion
We present mutations in OTOGL as a cause of nonsyn-
dromic deafness at the DFNB84 locus where mutations in
PTPRQ were previously discovered.7,21 We focused on
this genomic region because statistically significant
linkage was obtained in a genome scan and we found
a truncating mutation in OTOGL via whole exome
sequencing. A second multiplex family was independently
identified with two compound heterozygous mutations,
which provided further genetic support for the causative
role of OTOGLmutations in hearing loss. We subsequently
showed that OTOGL is preferentially expressed in the
inner ear in various species and that knocking down otogl
leads to sensorineural hearing loss in zebrafish. We thus
present mutations in OTOGL as a cause of hereditary deaf-
ness. The clinical phenotype is quite similar in the two
families with OTOGL mutations and is characterized by
a stable, moderate sensorineural hearing loss. One affected
person tested demonstrated vestibular abnormalities, indi-
cating that mutations in OTOGL may cause vestibular
dysfunction.
Sensory epithelia of the vertebrate inner ear consist of
highly organized arrays of sensory hair cells and supporting
cells. The acellular membranes of the inner ear form
intimate contact with the stereocilia bundles of the hair
cells. Each neuroepithelium of the inner ear is covered by
anacellular gelatinousmembrane: a voluminousgelatinous
substance formingadome-shaped cupula sits on topof each
crista in the ampullae of the semicircular canals. In the
utricle and saccule, an otoconial membrane loaded with
crystal-like structures, the otoconia, covers the surface of
the macula. In the cochlea, a tectorial membrane overlies
the auditory epithelia.28 These extracellularmatrices gener-
ally serve to either transmit the primary stimulus to the
stereocilia bundle or act as structures against which the
stereocilia bundles can react. They also serve to load the
bundles and change their resonance frequency.29 Acellular
membranes of the inner ear contain various collagens and
noncollagenous proteins that include a-tectorin (TECTA),
b-tectorin (TECTB), and otogelin (OTOG).28 In this study,
we show that otogelin-like is an additional component of
the inner ear acellular membranes that plays important
functional roles in hearing.The AmericanIn the mammalian inner ear, the cupula, the otoconial
membrane, and the tectorial membrane exhibit a progres-
sive increase in molecular and structural complexity, with
the cupula appearing the least complex and the tectorial
membrane the most complex.28 This increase of com-
plexity may reflect changes that occurred in the acellular
membranes of the inner ear as amammalian hearing organ
arose during evolution from a simple equilibrium
receptor.28 Otogelin was shown to be present in all three
membranes, suggesting a fundamental and ancient role
for this protein.28 Our study shows that the expression
pattern of otogelin-like is similar to that of otogelin by its
presence in all three acellular membranes of the inner ear
and in all four species analyzed; zebrafish, mouse, rat,
and human.
Our data show thatOtogl is mainly expressed in Claudius
cells, Hensen’s cells, and outer hair cells with a transcrip-
tion level that is high in embryonic, lower in neonatal,
and much lower in adult stages. The protein product,
however, is also prominently present in the acellular struc-
tures. High levels of transcription of Otogl in early and
downregulation of the gene in later development strongly
suggests that otogelin-like, similarly to other acellular
structure components such as otogelin, is normally
involved in the production of the structure, which may
require relatively low of gene activity for the maintenance
on the continuous basis.30
Although a human phenotype of OTOG mutations has
not been reported yet, targeted disruption of Otog resulted
in deafness and severe imbalance in mice.31 Histological
analysis of these mutants demonstrated that in the vesti-
bule, otogelin was required for the anchoring of the otoco-
nial membranes and cupulae to the neuroepithelia. In the
cochlea, ultrastructural analysis of the tectorial membrane
indicated that otogelin was involved in the organization of
its fibrillar network. Thus, otogelin is likely to have a role in
the resistance of this membrane to sound stimulation.31
Because of structural and expressional similarities, it is
possible that otogelin-like plays a similar role in the inner
ear. The clinical phenotype in humans with a stable
hearing loss and vestibular findings further supports this
possibility. On the other hand, the functions of otogelin-
like and otogelin are highly likely to be at least partially
noncompensatory, asmutations in each of the correspond-
ing genes can cause hearing loss.Supplemental Data
Supplemental Data includes four figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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